Search Results - Andrew Chase

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome by Andrew Chase, Catherine Bryant, Joannah Score, Nicholas C.P. Cross

    Published in Haematologica (2013-01-01)
    Get full text
    Article


  2. 2

    EZH2 in Myeloid Malignancies by Jenny Rinke, Andrew Chase, Nicholas C. P. Cross, Andreas Hochhaus, Thomas Ernst

    Published in Cells (2020-07-01)
    Get full text
    Article


  3. 3

    TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals by Andrew Chase, Thomas Ernst, Andreas Fiebig, Andrew Collins, Francis Grand, Philipp Erben, Andreas Reiter, Stefan Schreiber, Nicholas C.P. Cross

    Published in Haematologica (2010-01-01)
    Get full text
    Article


  4. 4

    A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α by Sebastian Kreil, Katherine Waghorn, Thomas Ernst, Andrew Chase, Helen White, Rüdiger Hehlmann, Andreas Reiter, Andreas Hochhaus, Nicholas C.P. Cross

    Published in Haematologica (2010-01-01)
    Get full text
    Article


  5. 5

    Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements by Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, Nicholas C.P. Cross

    Published in Haematologica (2013-03-01)
    Get full text
    Article


  6. 6

    Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms by Thomas Ernst, Andrew Chase, Katerina Zoi, Katherine Waghorn, Claire Hidalgo-Curtis, Joannah Score, Amy Jones, Francis Grand, Andreas Reiter, Andreas Hochhaus, Nicholas C.P. Cross

    Published in Haematologica (2010-09-01)
    Get full text
    Article


Search Tools: